HEALTH● LOWAug 28 · Aug 28, 2026, 11:24 AM
Lilly wins FDA label expansion for Mounjaro to reduce cardiovascular risk
Seeking Alpha Tech · north america
Eli Lilly's drug Mounjaro has received expanded approval from the FDA to reduce cardiovascular risk. This is an important development for patients and the medical field, potentially offering a new treatment option for heart health.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoHit a midlife wall? This test identifies your strengths and what matters to youNPR NewsHEALTH1h agoKerala State Drugs Control dept. seeks curbs on inter-State drug procurement to ensure traceabilityThe HinduHEALTH1h ago93% of children affected by diphtheria outbreaks not fully vaccinated – OfficialPremium TimesHEALTH1h agoDr. Sandra G. Martín, dentist: "Health always comes before a pretty tooth. First biology and then aesthetics. The important thing is that everything is healthy."Clarín